Table 2.
Summary of randomized histology-agnostic studies examined in this article. Data extracted from clinicaltrials.gov (October, 2018).
| Name | NCT Number | Enrollment | Start | End | Condition (Disease) | Sponsor |
|---|---|---|---|---|---|---|
| IMPACT II | NCT02152254 | 391 A,* | 2014 A,+ | 2020 E,+ | Metastatic Cancer | MDACC C |
| MPACT | NCT01827384 | 700 E,* | 2013 A,+ | 2019 E,+ | Advanced Malignant Solid Neoplasm | NCI |
| SHIVA | NCT01771458 | 742 A,* | 2012 A,+ | 2016 E,+ | Recurrent/Metastatic Solid Tumor | Institute Curie |
A Actual; E Estimated (expected); * Number of participants; + Year (of respective date); C Collaborator: Foundation Medicine; MDACC: M.D. Anderson Cancer Center; NCI: National Cancer Institute.